Va. Suits Alleging Janssen Cancer Drug 'Monopoly' Sent To NJ

By Christopher Cole (June 21, 2019, 6:27 PM EDT) -- A Virginia federal judge on Friday combined several class actions accusing Janssen Biotech of monopolizing sales of cancer drug Zytiga and sent them to New Jersey, saying not only does the case belong there but she doesn't want to overcrowd the Old Dominion court's docket....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!